Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,062 public trials 2,038 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Completed

A Phase I/II, Open-label Study of Ofatumumab Added to Chlorambucil in Previously Untreated Japanese Patients With Chronic Lymphocytic Leukemia

NCT01563055

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • GSK Investigational Site Aichi, Japan
  • GSK Investigational Site Hokkaido, Japan
  • GSK Investigational Site Kanagawa, Japan
  • GSK Investigational Site Kyoto, Japan
View Trial Details
Completed

Ofatumumab Versus Rituximab Salvage Chemoimmunotherapy Followed by Autologous Stem Cell Transplant in Relapsed or Refractory Diffuse Large B Cell Lymphoma

NCT01014208

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations
  • GSK Investigational Site Sacramento, California, United States
  • GSK Investigational Site New Haven, Connecticut, United States
  • GSK Investigational Site Chicago, Illinois, United States
  • GSK Investigational Site Chicago, Illinois, United States
View all 173 locations
View Trial Details
Completed

Plerixafor Plus Granulocyte Colony-stimulating Factor (G-CSF) For Mobilization And Collection Of Peripheral Hematopoietic Stem Cells In Japanese Participants With Multiple Myeloma

NCT02221479

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Investigational Site Number 392105 Kamogawa-Shi, Japan
  • Investigational Site Number 392103 Kyoto, Japan
  • Investigational Site Number 392102 Nagoya, Japan
  • Investigational Site Number 392104 Okayama, Japan
View Trial Details
Completed

Study of Thrombin Generation During the 3 First Cycles of Chemotherapy in Patients With Newly Diagnosed Multiple Myeloma

NCT01508416

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Embolism and Thrombosis, +14 more
Locations
  • CHU de Clermont Ferrand Clermont-Ferrand, France
  • CHU de Nancy Nancy, France
  • Service de Médecine Interne - CHU de Saint Etienne Saint-Etienne, France
  • Service de rhumatologie - CHU de Saint Etienne Saint-Etienne, France
View Trial Details
Completed

Allo SCT in Amyloidosis Non-interventional Study

NCT02257905

Conditions
AL Amyloidosis, Amyloidosis, Immune System Diseases, +10 more
Locations
  • CHRU Limoges Limoges, France
  • University Hospital Eppendorf Hamburg, Germany
  • University of Heidelberg Heidelberg, Germany
  • University Hospital Basel, Switzerland
View Trial Details

Related conditions